BiotechTubeBiotechTube
Home/Pipeline/Verzenio (abemaciclib)

Verzenio (abemaciclib)

Breast Cancer

ApprovedCommercial

Key Facts

Indication
Breast Cancer
Phase
Approved
Status
Commercial
Company
Eli Lilly

About Eli Lilly

Eli Lilly is one of the world's largest pharmaceutical companies with over 145 years of experience in developing life-changing medicines. The company has achieved significant recent success with GLP-1 receptor agonists for diabetes and weight management, generating substantial revenue growth. Lilly continues to invest heavily in R&D across key therapeutic areas including diabetes, oncology, autoimmune diseases, and neurodegeneration, with a robust pipeline of innovative treatments in development.

View full company profile

Therapeutic Areas

DiabetesOncologyImmunologyNeuroscienceObesityCardiovascular

Other Breast Cancer Drugs

DrugCompanyPhase
Pan-mutant-selective PI3Kα inhibitorNovartisAcquisition
TrodelvyRoyalty PharmaCommercial
Trastuzumab biosimilar (IBI306)Innovent BiologicsPhase 3
Ogivri (trastuzumab biosimilar)ViatrisApproved
Trastuzumab BiosimilarDr. Reddy's LaboratoriesApproved
Biosimilar TrastuzumabCiplaCommercial
Ogivri (Trastuzumab)BioconApproved
TamoxifenNatco PharmaApproved
ARV-027ArvinasPhase 1
Prognostic Genomic TestsEurobio ScientificCommercial
SelinexorKaryopharm TherapeuticsClinical Trials
ATNM-400Actinium PharmaceuticalsPreclinical